Back to Search

ROBERT FONTANA, MD

MD

Gastroenterology Physician

NPI: 1700968237IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

4301059767(MI)
Gastroenterology PhysicianPrimary

Internal Medicine — Gastroenterology

Code: 207RG0100X

4301059767(MI)

Education

UNIVERSITY OF MICHIGAN MEDICAL SCHOOL

Class of 1988

Research & Publications (20)

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
PMID 19132805·Drug Saf·2009
3-trial
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
PMID 19068241·Clin Gastroenterol Hepatol·2009
8-other
Side effects of long-term oral antiviral therapy for hepatitis B.
PMID 19399802·Hepatology·2009
8-other
Acute liver failure due to drugs.
PMID 18452117·Semin Liver Dis·2008
6-review
Assessment of the newly diagnosed patient with chronic hepatitis B virus infection.
PMID 19185071·Am J Med·2008
8-other
Should aciclovir be given to all patients presenting with acute liver failure of unknown etiology?
PMID 18477988·Nat Clin Pract Gastroenterol Hepatol·2008
8-other
Acute liver failure including acetaminophen overdose.
PMID 18570942·Med Clin North Am·2008
6-review
Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.
PMID 18721241·Am J Gastroenterol·2008
8-other
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
PMID 18175357·Hepatology·2008
8-other
Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
PMID 17465000·Hepatology·2007
4-observational
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.
PMID 17006909·Hepatology·2006
4-observational
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
PMID 16573786·Am J Gastroenterol·2006
2-rct
Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial.
PMID 16237784·J Hepatol·2005
3-trial
Acute liver failure due to amoxicillin and amoxicillin/clavulanate.
PMID 16187174·Dig Dis Sci·2005
5-case
Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond.
PMID 15324942·Gastroenterol Clin North Am·2004
6-review
Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis.
PMID 15017601·Clin Gastroenterol Hepatol·2004
4-observational
Management of patients with decompensated HBV cirrhosis.
PMID 12616454·Semin Liver Dis·2003
6-review
High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial.
PMID 11782615·J Clin Gastroenterol·2002
3-trial
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.
PMID 12004342·Liver Transpl·2002
4-observational
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.
PMID 12198698·Gastroenterology·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1500 EAST MEDICAL CENTER DR, 3RD FLOOR TAUBMAN CENTER RECP D
ANN ARBOR, MI 48109

Location

Practice Location

1500 EAST MEDICAL CENTER DR, ANN ARBOR, MI
(734) 647-5944

Quick Facts

NPI
1700968237
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
38
Publications
20

Are you this provider?

Claim Your Profile